Kynurenine

CAS No. 343-65-7

Kynurenine( Kynurenine )

Catalog No. M14171 CAS No. 343-65-7

Kynurenine is synthesized by the enzyme tryptophan dioxygenase, which is made primarily but not exclusively in the liver.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 33 In Stock
50MG 50 In Stock
100MG 77 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Kynurenine
  • Note
    Research use only, not for human use.
  • Brief Description
    Kynurenine is synthesized by the enzyme tryptophan dioxygenase, which is made primarily but not exclusively in the liver.
  • Description
    Kynurenine is synthesized by the enzyme tryptophan dioxygenase, which is made primarily but not exclusively in the liver, and indoleamine 2,3-dioxygenase, which is made in many tissues in response to immune activation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Kynurenine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    343-65-7
  • Formula Weight
    208.22
  • Molecular Formula
    C10H12N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(O)C(N)CC(C1=CC=CC=C1N)=O
  • Chemical Name
    alpha-2-Diamino-gamma-oxobenzenebutyric acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Liu JJ, et al. Biochim Biophys Acta. 2015 May;1852(5):980-91.
molnova catalog
related products
  • 1,7-dimethyl-1H-indo...

    1,7-dimethyl-1H-indole-3-carbaldehyde is a marine derived natural products found in Lyngbya majuscula.

  • DORA-22

    DORA-22 is a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memoryDORA-22, a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory.

  • BRD-K98645985

    BRD-K98645985 is a BAF (mammalian SWI/SNF) transcriptional repression inhibitor with an EC50 of ~2.37 μM. BRD-K98645985 binds ARID1A-specific BAF complexes, prevents nucleosomal positioning, and potently reverses HIV-1 latency, without T cell activation or toxicity.